• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

蛋白激酶 Cα 调控 KRIT1 的核质穿梭。

Protein kinase Cα regulates the nucleocytoplasmic shuttling of KRIT1.

机构信息

Department of Clinical and Biological Sciences, University of Torino, 10043 Orbassano, Torino, Italy

CCM Italia Research Network, National Coordination Center at the Department of Clinical and Biological Sciences, University of Torino, 10043 Orbassano, Torino, Italy.

出版信息

J Cell Sci. 2021 Feb 4;134(3):jcs250217. doi: 10.1242/jcs.250217.

DOI:10.1242/jcs.250217
PMID:33443102
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7875496/
Abstract

KRIT1 is a scaffolding protein that regulates multiple molecular mechanisms, including cell-cell and cell-matrix adhesion, and redox homeostasis and signaling. However, rather little is known about how KRIT1 is itself regulated. KRIT1 is found in both the cytoplasm and the nucleus, yet the upstream signaling proteins and mechanisms that regulate KRIT1 nucleocytoplasmic shuttling are not well understood. Here, we identify a key role for protein kinase C (PKC) in this process. In particular, we found that PKC activation promotes the redox-dependent cytoplasmic localization of KRIT1, whereas inhibition of PKC or treatment with the antioxidant N-acetylcysteine leads to KRIT1 nuclear accumulation. Moreover, we demonstrated that the N-terminal region of KRIT1 is crucial for the ability of PKC to regulate KRIT1 nucleocytoplasmic shuttling, and may be a target for PKC-dependent regulatory phosphorylation events. Finally, we found that silencing of PKCα, but not PKCδ, inhibits phorbol 12-myristate 13-acetate (PMA)-induced cytoplasmic enrichment of KRIT1, suggesting a major role for PKCα in regulating KRIT1 nucleocytoplasmic shuttling. Overall, our findings identify PKCα as a novel regulator of KRIT1 subcellular compartmentalization, thus shedding new light on the physiopathological functions of this protein.

摘要

KRIT1 是一种支架蛋白,可调节多种分子机制,包括细胞-细胞和细胞-基质黏附、氧化还原平衡和信号转导。然而,人们对 KRIT1 本身是如何被调节的知之甚少。KRIT1 存在于细胞质和细胞核中,但调节 KRIT1 核质穿梭的上游信号蛋白和机制尚未得到很好的理解。在这里,我们确定了蛋白激酶 C(PKC)在这个过程中的关键作用。特别是,我们发现 PKC 激活促进了 KRIT1 依赖氧化还原的细胞质定位,而 PKC 抑制或抗氧化剂 N-乙酰半胱氨酸的处理导致 KRIT1 核积累。此外,我们证明了 KRIT1 的 N 端区域对于 PKC 调节 KRIT1 核质穿梭的能力至关重要,并且可能是 PKC 依赖性调节磷酸化事件的靶点。最后,我们发现沉默 PKCα,但不是 PKCδ,可抑制佛波醇 12-肉豆蔻酸 13-乙酸酯(PMA)诱导的 KRIT1 细胞质富集,表明 PKCα 在调节 KRIT1 核质穿梭中起着主要作用。总的来说,我们的研究结果确定了 PKCα 是 KRIT1 亚细胞区室化的一种新型调节因子,从而为该蛋白的生理病理功能提供了新的认识。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9c38/7875496/8cb9ea4ead7d/joces-134-250217-g7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9c38/7875496/20cc97b91538/joces-134-250217-g1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9c38/7875496/c9eac50fcbda/joces-134-250217-g2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9c38/7875496/1846fb829be4/joces-134-250217-g3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9c38/7875496/0bc2a49b363a/joces-134-250217-g4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9c38/7875496/69f3446121be/joces-134-250217-g5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9c38/7875496/fa65bc0c6362/joces-134-250217-g6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9c38/7875496/8cb9ea4ead7d/joces-134-250217-g7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9c38/7875496/20cc97b91538/joces-134-250217-g1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9c38/7875496/c9eac50fcbda/joces-134-250217-g2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9c38/7875496/1846fb829be4/joces-134-250217-g3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9c38/7875496/0bc2a49b363a/joces-134-250217-g4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9c38/7875496/69f3446121be/joces-134-250217-g5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9c38/7875496/fa65bc0c6362/joces-134-250217-g6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9c38/7875496/8cb9ea4ead7d/joces-134-250217-g7.jpg

相似文献

1
Protein kinase Cα regulates the nucleocytoplasmic shuttling of KRIT1.蛋白激酶 Cα 调控 KRIT1 的核质穿梭。
J Cell Sci. 2021 Feb 4;134(3):jcs250217. doi: 10.1242/jcs.250217.
2
Serine phosphorylation of the small phosphoprotein ICAP1 inhibits its nuclear accumulation.丝氨酸磷酸化的小分子磷酸蛋白 ICAP1 抑制其核积累。
J Biol Chem. 2020 Mar 6;295(10):3269-3284. doi: 10.1074/jbc.RA119.009794. Epub 2020 Jan 31.
3
Mechanism of inhibition of sequestration of protein kinase C alpha/betaII by ceramide. Roles of ceramide-activated protein phosphatases and phosphorylation/dephosphorylation of protein kinase C alpha/betaII on threonine 638/641.神经酰胺抑制蛋白激酶Cα/βII隔离的机制。神经酰胺激活的蛋白磷酸酶的作用以及蛋白激酶Cα/βII在苏氨酸638/641处的磷酸化/去磷酸化作用。
J Biol Chem. 2007 Jul 13;282(28):20647-56. doi: 10.1074/jbc.M609162200. Epub 2007 May 15.
4
Nuclear Localization of Integrin Cytoplasmic Domain-associated Protein-1 (ICAP1) Influences β1 Integrin Activation and Recruits Krev/Interaction Trapped-1 (KRIT1) to the Nucleus.整合素胞质结构域相关蛋白-1(ICAP1)的核定位影响β1整合素激活并将Krev/相互作用捕获蛋白-1(KRIT1)招募至细胞核。
J Biol Chem. 2017 Feb 3;292(5):1884-1898. doi: 10.1074/jbc.M116.762393. Epub 2016 Dec 21.
5
KRIT1: A Traffic Warden at the Busy Crossroads Between Redox Signaling and the Pathogenesis of Cerebral Cavernous Malformation Disease.KRIT1:氧化还原信号与脑动静脉畸形病发病机制之间的繁忙十字路口的交通管理员。
Antioxid Redox Signal. 2023 Mar;38(7-9):496-528. doi: 10.1089/ars.2021.0263. Epub 2022 Nov 1.
6
Enhancement of glucagon secretion in mouse and human pancreatic alpha cells by protein kinase C (PKC) involves intracellular trafficking of PKCalpha and PKCdelta.蛋白激酶 C(PKC)增强小鼠和人胰腺α细胞中胰高血糖素的分泌涉及 PKCalpha 和 PKCdelta 的细胞内运输。
Diabetologia. 2010 Apr;53(4):717-29. doi: 10.1007/s00125-009-1635-x. Epub 2009 Dec 18.
7
The cerebral cavernous malformation disease causing gene KRIT1 participates in intestinal epithelial barrier maintenance and regulation.导致脑动静脉畸形的 KRIT1 基因参与肠道上皮屏障的维持和调节。
FASEB J. 2019 Feb;33(2):2132-2143. doi: 10.1096/fj.201800343R. Epub 2018 Sep 25.
8
Identification of the Kelch family protein Nd1-L as a novel molecular interactor of KRIT1.鉴定 Kelch 家族蛋白 Nd1-L 为 KRIT1 的一种新型分子相互作用蛋白。
PLoS One. 2012;7(9):e44705. doi: 10.1371/journal.pone.0044705. Epub 2012 Sep 6.
9
Differential role of PKC isoforms in GnRH and phorbol 12-myristate 13-acetate activation of extracellular signal-regulated kinase and Jun N-terminal kinase.蛋白激酶 C 同工型在 GnRH 和佛波醇 12-肉豆蔻酸 13-乙酸激活细胞外信号调节激酶和 Jun N-末端激酶中的差异作用。
Endocrinology. 2010 Oct;151(10):4894-907. doi: 10.1210/en.2010-0114. Epub 2010 Sep 1.
10
Protein Kinase Cα (PKCα) Is Resistant to Long Term Desensitization/Down-regulation by Prolonged Diacylglycerol Stimulation.蛋白激酶Cα(PKCα)对二酰基甘油长期刺激引起的长期脱敏/下调具有抗性。
J Biol Chem. 2016 Mar 18;291(12):6331-46. doi: 10.1074/jbc.M115.696211. Epub 2016 Jan 14.

引用本文的文献

1
Multidrug-Loaded Lipid Nanoemulsions for the Combinatorial Treatment of Cerebral Cavernous Malformation Disease.用于海绵状脑畸形疾病联合治疗的多药负载脂质纳米乳剂
Biomedicines. 2023 Feb 7;11(2):480. doi: 10.3390/biomedicines11020480.
2
Distant Recurrence of a Cerebral Cavernous Malformation in the Vicinity of a Developmental Venous Anomaly: Case Report of Local Oxy-Inflammatory Events.发育性静脉异常附近的脑海绵状血管畸形的远处复发:局部氧化炎症事件的病例报告。
Int J Mol Sci. 2022 Nov 24;23(23):14643. doi: 10.3390/ijms232314643.
3
Heterozygous Loss of KRIT1 in Mice Affects Metabolic Functions of the Liver, Promoting Hepatic Oxidative and Glycative Stress.

本文引用的文献

1
From Genes and Mechanisms to Molecular-Targeted Therapies: The Long Climb to the Cure of Cerebral Cavernous Malformation (CCM) Disease.从基因与机制到分子靶向治疗:治愈脑海绵状血管畸形(CCM)疾病的漫长征程。
Methods Mol Biol. 2020;2152:3-25. doi: 10.1007/978-1-0716-0640-7_1.
2
Vitamin D Deficiency and the Risk of Cerebrovascular Disease.维生素D缺乏与脑血管疾病风险
Antioxidants (Basel). 2020 Apr 17;9(4):327. doi: 10.3390/antiox9040327.
3
GPS 5.0: An Update on the Prediction of Kinase-specific Phosphorylation Sites in Proteins.
小鼠 KRIT1 杂合缺失影响肝脏的代谢功能,促进肝氧化应激和糖基化应激。
Int J Mol Sci. 2022 Sep 22;23(19):11151. doi: 10.3390/ijms231911151.
4
KRIT1: A Traffic Warden at the Busy Crossroads Between Redox Signaling and the Pathogenesis of Cerebral Cavernous Malformation Disease.KRIT1:氧化还原信号与脑动静脉畸形病发病机制之间的繁忙十字路口的交通管理员。
Antioxid Redox Signal. 2023 Mar;38(7-9):496-528. doi: 10.1089/ars.2021.0263. Epub 2022 Nov 1.
5
Is Location Everything? Regulation of the Endothelial CCM Signaling Complex.位置决定一切?内皮细胞CCM信号复合体的调控
Front Cardiovasc Med. 2022 Jul 11;9:954780. doi: 10.3389/fcvm.2022.954780. eCollection 2022.
6
Next-Generation Sequencing Advances the Genetic Diagnosis of Cerebral Cavernous Malformation (CCM).下一代测序技术推动了脑海绵状血管畸形(CCM)的基因诊断。
Antioxidants (Basel). 2022 Jun 29;11(7):1294. doi: 10.3390/antiox11071294.
7
Cerebral Cavernous Malformation Pathogenesis: Investigating Lesion Formation and Progression with Animal Models.颅内海绵状血管畸形的发病机制:利用动物模型研究病变形成和进展。
Int J Mol Sci. 2022 Apr 30;23(9):5000. doi: 10.3390/ijms23095000.
8
Contribution of protein-protein interactions to the endothelial-barrier-stabilizing function of KRIT1.蛋白-蛋白相互作用对 KRIT1 稳定内皮屏障功能的贡献。
J Cell Sci. 2022 Jan 15;135(2). doi: 10.1242/jcs.258816. Epub 2022 Jan 25.
GPS 5.0:蛋白质中激酶特异性磷酸化位点预测的更新。
Genomics Proteomics Bioinformatics. 2020 Feb;18(1):72-80. doi: 10.1016/j.gpb.2020.01.001. Epub 2020 Mar 19.
4
Dicarbonyl Stress and S-Glutathionylation in Cerebrovascular Diseases: A Focus on Cerebral Cavernous Malformations.脑血管疾病中的二羰基应激与S-谷胱甘肽化:聚焦于脑海绵状血管畸形
Antioxidants (Basel). 2020 Feb 1;9(2):124. doi: 10.3390/antiox9020124.
5
Serine phosphorylation of the small phosphoprotein ICAP1 inhibits its nuclear accumulation.丝氨酸磷酸化的小分子磷酸蛋白 ICAP1 抑制其核积累。
J Biol Chem. 2020 Mar 6;295(10):3269-3284. doi: 10.1074/jbc.RA119.009794. Epub 2020 Jan 31.
6
Cerebral Cavernous Malformation Proteins in Barrier Maintenance and Regulation.脑内海绵状血管畸形相关蛋白在血脑屏障维持和调节中的作用
Int J Mol Sci. 2020 Jan 20;21(2):675. doi: 10.3390/ijms21020675.
7
KRIT1 loss-mediated upregulation of NOX1 in stromal cells promotes paracrine pro-angiogenic responses.KRIT1 缺失介导的基质细胞中 NOX1 的上调促进旁分泌促血管生成反应。
Cell Signal. 2020 Apr;68:109527. doi: 10.1016/j.cellsig.2020.109527. Epub 2020 Jan 7.
8
KRIT1 Deficiency Promotes Aortic Endothelial Dysfunction.KRIT1 缺乏促进主动脉内皮功能障碍。
Int J Mol Sci. 2019 Oct 5;20(19):4930. doi: 10.3390/ijms20194930.
9
KRIT1 Loss-Of-Function Associated with Cerebral Cavernous Malformation Disease Leads to Enhanced -Glutathionylation of Distinct Structural and Regulatory Proteins.与脑海绵状血管畸形疾病相关的KRIT1功能丧失导致不同结构和调节蛋白的谷胱甘肽化增强。
Antioxidants (Basel). 2019 Jan 17;8(1):27. doi: 10.3390/antiox8010027.
10
Multifunctional Platinum@BSA-Rapamycin Nanocarriers for the Combinatorial Therapy of Cerebral Cavernous Malformation.用于海绵状脑畸形联合治疗的多功能铂@牛血清白蛋白-雷帕霉素纳米载体
ACS Omega. 2018 Nov 30;3(11):15389-15398. doi: 10.1021/acsomega.8b01653. Epub 2018 Nov 13.